Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis

European Journal of Medicinal Chemistry
2015.0

Abstract

Multi-drug resistant (MDR) and extremely drug resistant (XDR) Mycobacterium tuberculosis strains have turned tuberculosis (TB) as "on the verge of eradication" to "most life threatening" disease. Furthermore, synergy with HIV and other immunosuppressive disease have strengthened its prevalence. This research reports small molecule anti-infectives which are specifically potent against several strains and isolates of TB. The hit compound 7f has also proved to be active against almost 25 clinical isolates comparable to marketed anti-TB agents.

Knowledge Graph

Similar Paper

Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis
European Journal of Medicinal Chemistry 2015.0
Identification and development of 2,5-disubstituted oxadiazole as potential candidate for treatment of XDR and MDR tuberculosis
European Journal of Medicinal Chemistry 2012.0
Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors
European Journal of Medicinal Chemistry 2019.0
Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents
ACS Medicinal Chemistry Letters 2015.0
Design, synthesis and investigation on the structure–activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents
European Journal of Medicinal Chemistry 2014.0
Structure−Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and NonreplicatingMycobacterium tuberculosis
Journal of Medicinal Chemistry 2009.0
Synthesis and evaluation of thiophene based small molecules as potent inhibitors of Mycobacterium tuberculosis
European Journal of Medicinal Chemistry 2020.0
A novel molecule with notable activity against multi-drug resistant tuberculosis
Bioorganic & Medicinal Chemistry Letters 2015.0
1,4–Diarylpiperazines and analogs as anti-tubercular agents: Synthesis and biological evaluation
European Journal of Medicinal Chemistry 2012.0
Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains
Bioorganic & Medicinal Chemistry Letters 2011.0